George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetra Diamonds Regulatory News (PDL)

Share Price Information for Petra Diamonds (PDL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.80
Bid: 44.50
Ask: 45.00
Change: 3.60 (8.74%)
Spread: 0.50 (1.124%)
Open: 42.00
High: 45.00
Low: 42.00
Prev. Close: 41.20
PDL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

28 Oct 2016 15:45

RNS Number : 7830N
Petra Diamonds Limited
28 October 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

PETRA DIAMONDS LTD

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

T. Rowe Price Associates, Inc.

4. Full name of shareholder(s)  (if different from 3.):

Bank of New York Mellon Bank, N.A.

JP Morgan Chase

Northern Trust Co.

State Street Bank & Trust Co.

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

26 October 2016

6. Date on which issuer notified:

28 October 2016

7. Threshold(s) that is/are crossed orreached:

11%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

BMG702781094

58,664,303

58,611,990

58,009,224

57,956,911

10.93%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

57,956,911

10.93%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of Petra Diamonds Ltd., including the T. Rowe Price New Era Fund, Inc., which owns 8,833,248 shares. Such shares are registered in the following name(s):

 

Bank of New York Mellon Bank, N.A. - 2,473,855

 

JP Morgan Chase - 13,239,470

 

Northern Trust Co. - 1,648,517

 

State Street Bank & Trust Co. - 40,595,069

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Gary Greb, Vice President

T. Rowe Price Associates, Inc.

15. Contact telephone number:

001 410 345 2527

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMPBITMBITBJF
Date   Source Headline
16th Apr 20247:00 amPRNQ3 FY 2024 Operating Update and Final Sales Results for Tender 5 FY 2024
9th Apr 20247:00 amPRNNotification of Q3 FY 2024 Operating Update
8th Apr 20247:00 amPRNCost savings target increased to more than US$30m per annum and entry into definitive transaction agreement for the sale of Koffiefontein.
8th Mar 20247:23 amPRNDirectorate Change
20th Feb 20247:00 amRNSH1 FY 2024 Interim Results
16th Feb 20247:00 amRNSFinal sales results for Tender 4 FY 2024
13th Feb 20247:00 amRNSNotification of H1 FY 2024 Interim Results
18th Jan 20247:00 amRNSDirector Share Awards
16th Jan 20247:00 amRNSH1 FY 2024 Operating Update
10th Jan 20247:00 amRNSNotification of H1 FY 2024 Operating Update
21st Dec 202310:40 amRNSDirectorate Change
20th Dec 20237:00 amRNSBoard Changes
14th Dec 20237:00 amRNSFinal sales results for Tender 3 FY 2024
13th Dec 202310:47 amRNSPotential Sale of Koffiefontein
8th Dec 20231:00 pmRNSHolding(s) in Company
8th Dec 202311:23 amRNSListing Rule 9.6.14 (R) Disclosure
8th Dec 20237:00 amRNSInitial sales results for Tender 3 FY 2024
8th Dec 20237:00 amRNSApproval of increase in Revolving Credit Facility
6th Dec 202312:25 pmRNSHolding(s) in Company
14th Nov 202311:06 amRNSResult of AGM
13th Nov 20232:45 pmRNSDirectorate Change
8th Nov 20234:03 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSImproved resilience through capital deferrals
24th Oct 20233:21 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSQ1 FY 2024 Operating Update
19th Oct 20237:00 amRNSDirector Share Awards
19th Oct 20237:00 amRNSDirector Share Vesting
17th Oct 20237:01 amRNSNotification of Q1 FY 2024 Operating Update
17th Oct 20237:00 amRNSSales results for Tender 2 FY 2024
11th Oct 202310:54 amRNSHolding(s) in Company
10th Oct 20237:00 amRNSPublication of 2023 Reports and Notice of AGM
6th Oct 20237:00 amRNSInitial sales results for 75% of Tender 2 FY 2024
15th Sep 20237:01 amRNSDirectorate Change
15th Sep 20237:00 amRNSPreliminary Results for FY 2023
11th Sep 202311:10 amRNSShort delay of FY 2023 Preliminary Results
5th Sep 20237:00 amRNSNotification of FY 2023 Preliminary Results
25th Aug 20237:00 amRNSFirst tender of FY 2024 yields US$79.3m in sales
10th Aug 20232:15 pmRNSHolding(s) in Company
9th Aug 202310:04 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSQ4 and FY 2023 Operating Update
12th Jul 20237:00 amRNSNotification of Q4 and FY 2023 Operating Update
28th Jun 20237:00 amRNSPublication of Presentation
7th Jun 20237:00 amRNSPostponement of Tender 6 FY 2023
31st May 20237:00 amRNSClass 2 Announcement
19th May 20234:00 pmRNSHolding(s) in Company
19th May 20237:00 amRNSSales results for Tender 5 FY 2023
9th May 20238:55 amRNSDirector Declaration
25th Apr 202310:00 amRNSHolding(s) in Company
24th Apr 202310:00 amRNSHolding(s) in Company
21st Apr 202310:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.